Hepatitis C among people who use drugs

The increasing burden of hepatitis C remains underestimated by many policy makers, professionals and the public. There is, however, considerable evidence and expertise upon which guidance for effectively tackling hepatitis C in Europe can draw.
The key messages included in this report represent the most important aspects of interventions targeting injecting drug users. These have been identified through field work, the day to day experience of practitioners and a literature review.